RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 12-22
  • Chile peppers can help with neuropathic pain--maybe, a little

     
    If you suffer from neuropathic pain, there's new evidence that capsaicin--the stuff in chile peppers that gives them their zing--might help you. A new review found that capsaicin helps 4 in 10 people who suffer from such pain, which is......
  • FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated]

     
    The Food and Drug Administration today approved Cervarix, the vaccine against human papilloma virus (HPV) manufactured by GlaxoSmithKline, for use in girls and young women ages 10 to 25. An FDA adivsory panel recommended approval of the vaccine on Sept......
  • CDC panel OKs use of Cervarix HPV vaccine in girls, Gardasil in boys

     
    The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted today to recommend the use of the Cervarix human papilloma virus (HPV) vaccine in girls age 11 and 12. Cervarix was approved by the Food and Drug......
  • Dow at new one-year high as stocks jump worldwide

     
    The bears are being routed worldwide today as investors find plenty of reasons to buy stocks and not many reasons to sell. The Dow Jones industrial average was trading at a new one-year high at about 11 a.m. PST, up......
  • Four Latino Angelenos win scholarships for math, science

     
    In an effort to bring more Latino youth into science and technology, the National Alliance for Hispanic Health today announced 10 students (four of them Angelenos) won a $42,500 scholarship for college tuition and internship support. Over the next five......
  • Vytorin trial shows little or no benefit against heart disease [Updated]

     
    For the second time in as many years, a large clinical trial has found that the key ingredient in the heavily advertised drug Vytorin provides little or no benefit in preventing heart disease compared to a competing product. The ingredient......
  • Cold virus may have caused 2007 AIDS vaccine trial failure

     
    One of the biggest disappointments in AIDS research was the failure of Merck & Co.'s STEP trial of an experimental AIDS vaccine, which was terminated prematurely in 2007 when it became apparent that the vaccine seemed to increase the number......
  • Consumers didn't have the information they needed on this lemon: Vioxx

     
    Thirty studies involving more than 20,000 people demonstrated an increased risk of heart attacks and strokes linked to the drug Vioxx, which was taken off the market in 2004 after generating billions of dollars annually in sales. However, this...
  • Morning Money Links: Happy holidays for health-care stocks; the Fed's many failures; Twitter makes money

     
    --- Christmas came early for health-care stocks: They’re up across the board today after the Senate’s critical vote on Sunday to advance a health-care reform bill that doesn’t include creation of a government-run competitor. New 52-week highs for...
  • Wall Street bets on a GOP win in Massachusetts

     
    Wall Street thinks it knows the outcome of today’s Massachusetts special election for the late Ted Kennedy’s Senate seat. Stocks are broadly higher, led by healthcare issues, as some investors bet that Kennedy’s seat will go to Republican challenger...
  • Oral multiple sclerosis drug shows promise

     
    A large study on a new oral medication for multiple sclerosis has yielded promising results both in terms of how well the drug works and its safety, according to a study published today in the New England Journal of Medicine.......